The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 02, 2017
Filed:
Jan. 10, 2014
Applicant:
Gilead Pharmasset Llc, Foster City, CA (US);
Inventors:
Byoung-Kwon Chun, Robbinsville, NJ (US);
Ganapati Reddy Pamulapati, San Ramon, CA (US);
Suguna Rachakonda, Twinsburg, OH (US);
Bruce Ross, El Granada, CA (US);
Michael Joseph Sofia, Doylestown, PA (US);
Peiyuan Wang, Totowa, NJ (US);
Hai-Ren Zhang, San Jose, CA (US);
Assignee:
Gilead Pharmasset LLC, Foster City, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 19/10 (2006.01); A61K 31/7072 (2006.01); A61K 45/00 (2006.01); C07F 9/24 (2006.01); A61K 31/716 (2006.01); C07H 17/02 (2006.01); C07F 9/6558 (2006.01); C07H 1/00 (2006.01);
U.S. Cl.
CPC ...
C07H 19/10 (2013.01); A61K 31/7072 (2013.01); A61K 31/716 (2013.01); A61K 45/00 (2013.01); C07F 9/24 (2013.01); C07F 9/242 (2013.01); C07F 9/65586 (2013.01); C07H 1/00 (2013.01); C07H 17/02 (2013.01);
Abstract
Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.